Concepedia

Author

Hans Rydholm

AstraZeneca (Sweden)

Also Known As

H E Rydholm, H RYDHOLM, H. E. Rydholm, H. RYDHOLM, H. Rydholm, Hans Rydholm

30

Publications

493

Citations

10

H-Index

13

Concepts

All Affiliations

AstraZeneca (Sweden)KU LeuvenUniversity Medical Center UtrechtAstraZeneca (United Kingdom)Amsterdam UMC Location University of Amsterdam
HR

About

Hans Rydholm is an author at AstraZeneca (Sweden) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

79

2

Pharmacology

2

2

68

3

Social Sciences

1

1

11

4

Gastroenterology

1

1

11

5

Psychiatry

1

1

11

Hans Rydholm

×

10

Publications

438

Citations

10

H-Index

YearCitations

The effect of baclofen on gastro‐oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease

Margot A. van Herwaarden, Melvin Samsom, Hans Rydholm,

Alimentary Pharmacology & Therapeutics

2002

107

Baclofen‐mediated gastro‐oesophageal acid reflux control in patients with established reflux disease

Lars Cange, Erik Johnsson, Hans Rydholm,

Alimentary Pharmacology & Therapeutics

2002

86

Effect of lesogaberan, a novel GABA<sub>B</sub>‐receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects

Guy E. Boeckxstaens, Hans Rydholm, Aaltje Lei,

Alimentary Pharmacology & Therapeutics

2010

59

Rapid initial gastric emptying and hypersensitivity to gastric filling in functional dyspepsia: Effects of duodenal lipids

Johan A. Lunding, Solomon Tefera, Odd Helge Gilja,

Scandinavian Journal of Gastroenterology

2006

47

Esomeprazole (E) 40 mg provides more effective acid control than pantoprazole (P) 40 mg

Clive H. Wilder‐Smith, Kerstin Röhss, Christina Lundin,

Gastroenterology

2000

47

The GABA<sub>B</sub> receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study

Hanneke Beaumont, A. J. P. M. Smout, Marissa C. Aanen,

Alimentary Pharmacology & Therapeutics

2009

27

Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg

Kerstin Röhss, Catharina Claar-Nilsson, Hans Rydholm,

Gastroenterology

2000

21

Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) synthesis in cultured human umbilical vein endothelium

Hans Rydholm, S. Boström, E. Eriksson,

Scandinavian Journal of Clinical and Laboratory Investigation

1995

17

Prevention of upper gastrointestinal bleeding in critically ill Chinese patients: a randomized, double-blind study evaluating esomeprazole and cimetidine

Wenhui Lou, Ying Xia, Xiang Peng,

Current Medical Research and Opinion

2018

16

Effects of Body Awareness Therapy in Patients with Irritable Bowel Syndrome

E. Eriksson, V. Nordwall, Göran Kurlberg,

Advances in Physiotherapy

2002

11

Page 1